REPS1
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
RALBP1 associated Eps domain containing 1 | MIM:614825 | Ensembl:ENSG00000135597 | HGNC:HGNC:15578 | PA34329 | 6q24.1 |
GO terms in REPS1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0005509 | calcium ion binding |
MF | IPI | GO:0005515 | protein binding |
MF | IPI | GO:0017124 | SH3 domain binding |
BP | IEA | GO:0006898 | receptor-mediated endocytosis |
BP | TAS | GO:0061024 | membrane organization |
CC | TAS | GO:0005829 | cytosol |
CC | IDA | GO:0005886 | plasma membrane |
CC | IDA | GO:0005905 | clathrin-coated pit |
Gene expression in normal tissue: REPS1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in REPS1
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-199991 | Membrane Trafficking |
reactome | R-HSA-5653656 | Vesicle-mediated transport |
reactome | R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis |
reactome | R-HSA-8856828 | Clathrin-mediated endocytosis |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD144 | NSC95397 | 3 |
iGMDRD84 | Lovastatin acid | 2 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD607 | Ubistatin B | 3 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD237 | ABT-751 | 4 |
iGMDRD152 | 179324-69-7 | 4 |
iGMDRD57 | Chloropentafluorobenzene | 6 |
iGMDRD171 | Pemetrexed | 3 |
iGMDRD6 | AM-580 | 2 |
iGMDRD221 | Tamoxifen | 2 |
iGMDRD77 | Itraconazole | 3 |
iGMDRD441 | TW 37 | 2 |
iGMDRD121 | GMX1778 | 2 |
iGMDRD872 | BRD7137 | 2 |
iGMDRD414 | MST-312 | 2 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD100 | Zebularine | 3 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD67 | PENFLURIDOL | 5 |
iGMDRD398 | Sepantronium | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in REPS1